Details of the Drug
General Information of Drug (ID: DMWS35F)
Drug Name |
(4-((1H-imidazol-1-yl)methyl)phenyl)methanol
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
[4-(1H-Imidazol-1-ylmethyl)phenyl]methanol; 103573-92-8; CHEMBL590987; (4-((1H-imidazol-1-yl)methyl)phenyl)methanol; {4-[(1H-Imidazol-1-yl)methyl]phenyl}methanol; [4-(imidazol-1-ylmethyl)phenyl]methanol; SCHEMBL10661787; CTK8G4735; DTXSID80575387; FSLVBXCLXDGFRE-UHFFFAOYSA-N; MolPort-000-143-260; SBB090788; ZINC12370277; BDBM50307211; AKOS006344218; RP03593; [4-(imidazolylmethyl)phenyl]methan-1-ol; KB-63739; DB-059022; 4-(1H-Imidazole-1-ylmethyl)benzenemethanol; Y6875; FT-0708208; 4-((1H-imidazol-1-yl)methyl)phenylmethanol
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 188.23 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 0.7 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 3 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 2 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||